Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2018, Article ID 3718437, 8 pages
https://doi.org/10.1155/2018/3718437
Research Article

How Could We Influence Systemic Inflammation in Allergic Rhinitis? The Role of H1 Antihistamines

1Department of Allergology and Immunology, “Iuliu Hatieganu” University of Medicine and Pharmacy, Cluj Napoca, Romania
2Department of Pharmacology, Toxicology and Clinical Pharmacology, “Iuliu Hatieganu” University of Medicine and Pharmacy, Cluj Napoca, Romania
3Department of Clinical Immunology, Sahlgrenska University Hospital, Göteborg, Sweden

Correspondence should be addressed to Ioana Corina Bocsan; moc.oohay@nascobaniroc

Received 17 February 2018; Revised 13 April 2018; Accepted 15 May 2018; Published 12 June 2018

Academic Editor: Ada Popolo

Copyright © 2018 Ioana Adriana Muntean et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Bousquet, N. Khaltaev, A. A. Cruz et al., “Allergic rhinitis and its impact on asthma (ARIA) 2008,” Allergy, vol. 63, pp. 8–160, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. J. Bousquet, H. J. Schünemann, T. Zuberbier et al., “Development and implementation of guidelines in allergic rhinitis – an ARIA-Ga2len paper,” Allergy, vol. 65, no. 10, pp. 1212–1221, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. B. Leynaert, C. Neukirch, S. Kony et al., “Association between asthma and rhinitis according to atopic sensitization in a population-based study,” The Journal of Allergy and Clinical Immunology, vol. 113, no. 1, pp. 86–93, 2004. View at Publisher · View at Google Scholar · View at Scopus
  4. R. H. Schwartz, “T cell anergy,” Annual Review of Immunology, vol. 21, no. 1, pp. 305–334, 2003. View at Publisher · View at Google Scholar · View at Scopus
  5. M. L. Kowalski and R. Alam, “Signal transduction mechanisms as new targets for allergists,” Allergy, vol. 56, no. 3, pp. 199–203, 2001. View at Publisher · View at Google Scholar · View at Scopus
  6. M. F. Kramer, T. R. Jordan, C. Klemens et al., “Factors contributing to nasal allergic late phase eosinophilia,” American Journal of Otolaryngology, vol. 27, no. 3, pp. 190–199, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. H. Tachimoto, S. A. Hudson, and B. S. Bochner, “Acquisition and alteration of adhesion molecules during cultured human mast cell differentiation,” The Journal of Allergy and Clinical Immunology, vol. 107, no. 2, pp. 302–309, 2001. View at Publisher · View at Google Scholar · View at Scopus
  8. B. S. Bochner, Adhesion Molecules in Allergic Disease, Marcel Dekker, New York, 1997.
  9. B. S. Bochner, D. A. Klunk, S. A. Sterbinsky, R. L. Coffman, and R. P. Schleimer, “IL-13 selectively induces vascular cell adhesion molecule-1 expression in human endothelial cells,” The Journal of Immunology, vol. 154, no. 2, pp. 799–803, 1995. View at Google Scholar
  10. Y. Ohashi, Y. Nakai, A. Tanaka et al., “Soluble vascular cell adhesion molecule-1 in perennial allergic rhinitis,” Acta Oto-Laryngologica, vol. 118, no. 1, pp. 105–109, 1998. View at Google Scholar
  11. G. M. Walsh, “The effects of cetirizine on the function of inflammatory cells involved in the allergic response,” Clinical and Experimental Allergy, vol. 27, Supplement 2, pp. 47–53, 1997. View at Publisher · View at Google Scholar
  12. M. Branco-Ferreira, M. C. dos Santos, M. L. Palma-Carlos, and A. G. Palma-Carlos, “Antihistamines and serum adhesion molecule levels,” Allergie et Immunologie, vol. 33, no. 6, pp. 233–236, 2001. View at Google Scholar
  13. C. Schäper, B. Gustavus, B. Koch et al., “Effects of fexofenadine on inflammatory mediators in nasal lavage fluid in intermittent allergic rhinitis,” Journal of Investigational Allergology & Clinical Immunology, vol. 19, no. 6, pp. 459–464, 2009, 20128420. View at Google Scholar
  14. J. Mullol, F. de Borja Callejas, M. A. Martínez-Antón et al., “Mometasone and desloratadine additive effect on eosinophil survival and cytokine secretion from epithelial cells,” Respiratory Research, vol. 12, no. 1, p. 23, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. D. Tworek, M. Bocheńska-Marciniak, M. Kupczyk, P. Górski, and P. Kuna, “The effect of 4 weeks treatment with desloratadine (5mg daily) on levels of interleukin (IL)-4, IL-10, IL-18 and TGF beta in patients suffering from seasonal allergic rhinitis,” Pulmonary Pharmacology & Therapeutics, vol. 20, no. 3, pp. 244–249, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. C. I. Bocşan, A. I. Bujor, N. Miron, Ş. C. Vesa, D. Deleanu, and A. D. Buzoianu, “In vivo anti-inflammatory effect of H1 antihistamines in allergic rhinitis: a randomized clinical trial,” Balkan Medical Journal, vol. 32, no. 4, pp. 352–358, 2015. View at Publisher · View at Google Scholar · View at Scopus
  17. L. Heinzerling, A. Mari, K. C. Bergmann et al., “The skin prick test - European standards,” Clinical and Translational Allergy, vol. 3, no. 1, p. 3, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. American Thoracic Society and European Respiratory Society, “ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005,” American Journal of Respiratory and Critical Care Medicine, vol. 171, no. 8, pp. 912–930, 2005. View at Publisher · View at Google Scholar · View at Scopus
  19. G. W. Canonica and E. Compalati, “Minimal persistent inflammation in allergic rhinitis: implications for current treatment strategies,” Clinical & Experimental Immunology, vol. 158, no. 3, pp. 260–271, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. A. Togias, “Unique mechanistic features of allergic rhinitis,” The Journal of Allergy and Clinical Immunology, vol. 105, Part 2, no. 6, pp. S599–S604, 2000. View at Publisher · View at Google Scholar · View at Scopus
  21. L. Borish, “Allergic rhinitis: systemic inflammation and implications for management,” The Journal of Allergy and Clinical Immunology, vol. 112, no. 6, pp. 1021–1031, 2003. View at Publisher · View at Google Scholar · View at Scopus
  22. D. J. Adamko, S. O. Odemuyiwa, D. Vethanayagam, and R. Moqbel, “The rise of the phoenix: the expanding role of the eosinophil in health and disease,” Allergy, vol. 60, no. 1, pp. 13–22, 2005. View at Publisher · View at Google Scholar · View at Scopus
  23. A. Ural, M. S. Tezer, A. Yücel, H. Atilla, and F. Ileri, “Interleukin-4, interleukin-8 and E-selectin levels in intranasal polyposis patients with and without allergy: a comparative study,” The Journal of International Medical Research, vol. 34, no. 5, pp. 520–524, 2006. View at Publisher · View at Google Scholar · View at Scopus
  24. M. Turgay, G. Keskin, G. Kminkli et al., “Soluble intercellular adhesion molecule-1 (sICAM-1) in patients with allergic rhinoconjunctivitis,” Allergol Immunopathol (Madr), vol. 24, no. 3, pp. 129–131, 1996. View at Google Scholar
  25. C. M. Liu, C. T. Shun, and Y. K. Cheng, “Soluble adhesion molecules and cytokines in perennial allergic rhinitis,” Annals of Allergy, Asthma & Immunology, vol. 81, no. 2, pp. 176–180, 1998. View at Publisher · View at Google Scholar · View at Scopus
  26. L. Håkansson, C. Heinrich, S. Rak, and P. Venge, “Priming of eosinophil adhesion in patients with birch pollen allergy during pollen season: effect of immunotherapy,” The Journal of Allergy and Clinical Immunology, vol. 99, no. 4, pp. 551–562, 1997. View at Publisher · View at Google Scholar · View at Scopus
  27. M. Gorska-Ciebiada, M. Ciebiada, M. M. Gorska, P. Gorski, and I. Grzelewska-Rzymowska, “Intercellular adhesion molecule 1 and tumor necrosis factor α in asthma and persistent allergic rhinitis: relationship with disease severity,” Annals of Allergy, Asthma & Immunology, vol. 97, no. 1, pp. 66–72, 2006. View at Publisher · View at Google Scholar · View at Scopus
  28. B. J. Lee, R. M. Naclerio, B. S. Bochner, R. M. Taylor, M. C. Lim, and F. M. Baroody, “Nasal challenge with allergen upregulates the local expression of vascular endothelial adhesion molecules,” The Journal of Allergy and Clinical Immunology, vol. 94, Part 1, no. 6, pp. 1006–1016, 1994. View at Publisher · View at Google Scholar · View at Scopus
  29. M. Ciebiada, M. Gorska-Ciebiada, and P. Gorski, “sICAM-1 and TNF-α in asthma and rhinitis: relationship with the presence of atopy,” The Journal of Asthma, vol. 48, no. 7, pp. 660–666, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. Y. Li, Y. Wang, and Q. Zhang, “Expression of cell adhesion molecule and nitric oxide synthase in nasal mucosa in allergic rhinitis,” Lin Chuang Er Bi Yan Hou Ke Za Zhi, vol. 20, no. 7, pp. 315–318, 2006. View at Google Scholar
  31. T. R. Jordan, E. Pfrogner, G. Rasp, and M. F. Kramer, “Clinical symptoms and mediators in the allergic early and late phase reaction,” Laryngo- Rhino- Otologie, vol. 85, no. 2, pp. 113–123, 2006. View at Publisher · View at Google Scholar · View at Scopus
  32. T. Matsui, K. Asakura, H. Shirasaki, A. Kataura, and T. Himi, “Relationship between infiltrating cells and adhesion molecules in the nasal mucosa of patients with allergic rhinitis,” Acta Oto-Laryngologica, vol. 120, no. 8, pp. 973–980, 2000. View at Google Scholar
  33. R. M. Naclerio, “Pathophysiology of perennial allergic rhinitis,” Allergy, vol. 52, Supplement 36, pp. 7–13, 1997. View at Publisher · View at Google Scholar
  34. D. Aronsson, E. Tufvesson, and L. Bjermer, “Allergic rhinitis with or without concomitant asthma: difference in perception of dyspnoea and levels of fractional exhaled nitric oxide,” Clinical & Experimental Allergy, vol. 35, no. 11, pp. 1457–1461, 2005. View at Publisher · View at Google Scholar · View at Scopus
  35. C. Gratziou, M. Lignos, M. Dassiou, and C. Roussos, “Influence of atopy on exhaled nitric oxide in patients with stable asthma and rhinitis,” The European Respiratory Journal, vol. 14, no. 4, pp. 897–901, 1999. View at Publisher · View at Google Scholar · View at Scopus
  36. R. Mösges and L. Klimek, “Today’s allergic rhinitis patients are different: new factors that may play a role,” Allergy, vol. 62, no. 9, pp. 969–975, 2007. View at Publisher · View at Google Scholar · View at Scopus
  37. H. Widegren, J. Erjefält, M. Korsgren, M. Andersson, and L. Greiff, “Effects of intranasal TNFalpha on granulocyte recruitment and activity in healthy subjects and patients with allergic rhinitis,” Respiratory Research, vol. 9, no. 1, p. 15, 2008. View at Publisher · View at Google Scholar · View at Scopus
  38. C. Bachert, “A review of the efficacy of desloratadine, fexofenadine, and levocetirizine in the treatment of nasal congestion in patients with allergic rhinitis,” Clinical Therapeutics, vol. 31, no. 5, pp. 921–944, 2009. View at Publisher · View at Google Scholar · View at Scopus
  39. P. H. Howarth, M. A. Stern, L. Roi, R. Reynolds, and J. Bousquet, “Double-blind, placebo-controlled study comparing the efficacy and safety of fexofenadine hydrochloride (120 and 180 mg once daily) and cetirizine in seasonal allergic rhinitis,” The Journal of Allergy and Clinical Immunology, vol. 104, no. 5, pp. 927–933, 1999. View at Publisher · View at Google Scholar · View at Scopus
  40. Van Cauwenberge, Juniper, and The STAR study investigating group, “Comparison of the efficacy, safety and quality of life provided by fexofenadine hydrochloride 120 mg, loratadine 10 mg and placebo administered once daily for the treatment of seasonal allergic rhinitis,” Clinical and Experimental Allergy, vol. 30, no. 6, pp. 891–899, 2000. View at Publisher · View at Google Scholar · View at Scopus
  41. D. K. Agrawal, “Anti-inflammatory properties of desloratadine,” Clinical and Experimental Allergy, vol. 34, no. 9, pp. 1342–1348, 2004. View at Publisher · View at Google Scholar · View at Scopus
  42. F. Marcucci, L. Giovanna Sensi, P. Abate et al., “Anti-inflammatory activity and clinical efficacy of a 3-month levocetirizine therapy in mite-allergic children,” Inflammation & Allergy Drug Targets, vol. 10, no. 1, pp. 32–38, 2011. View at Publisher · View at Google Scholar · View at Scopus
  43. J. L. Brozek, C. E. Baena-Cagnani, S. Bonini et al., “Methodology for development of the allergic rhinitis and its impact on asthma guideline 2008 update,” Allergy, vol. 63, no. 1, pp. 38–46, 2008. View at Publisher · View at Google Scholar · View at Scopus
  44. M. Ciebiada, M. Barylski, and M. G. Ciebiada, “Nasal eosinophilia and serum soluble intercellular adhesion molecule 1 in patients with allergic rhinitis treated with montelukast alone or in combination with desloratadine or levocetirizine,” American Journal of Rhinology & Allergy, vol. 27, no. 2, pp. 58–62, 2013. View at Publisher · View at Google Scholar · View at Scopus
  45. R. Maiti, J. Rahman, J. Jaida, U. Allala, and A. Palani, “Rupatadine and levocetirizine for seasonal allergic rhinitis: a comparative study of efficacy and safety,” Archives of Otolaryngology – Head & Neck Surgery, vol. 136, no. 8, pp. 796–800, 2010. View at Publisher · View at Google Scholar · View at Scopus
  46. A. Muntean, I. C. Bocsan, and D. M. Deleanu, “The effect of H1-antihistamines on allergic inflammation in patients with allergic rhinitis,” Human & Veterinary Medicine, vol. 8, no. 4, pp. 161–165, 2016. View at Google Scholar
  47. J. Králová, L. Račková, M. Pekarová et al., “The effects of H1-antihistamines on the nitric oxide production by RAW 264.7 cells with respect to their lipophilicity,” International Immunopharmacology, vol. 9, no. 7-8, pp. 990–995, 2009. View at Publisher · View at Google Scholar · View at Scopus
  48. L. Bennedich Kahn, L. E. Gustafsson, and C. Olgart Höglund, “Nerve growth factor enhances neurokinin A-induced airway responses and exhaled nitric oxide via a histamine-dependent mechanism,” Pulmonary Pharmacology & Therapeutics, vol. 21, no. 3, pp. 522–532, 2008. View at Publisher · View at Google Scholar · View at Scopus